IP Library Granted Patent US 9,234,864
Granted Patent B2
US 9,234,864 · App. 14/463,444 · Granted Jan 12, 2016

Small volume in vitro analyte sensor

Inventors: Adam Heller (Austin, TX); Benjamin J. Feldman (Berkeley, CA); James L. Say (Breckenridge, CO); Mark S. Vreeke (Granger, IN)
Assignee: Abbott Diabetes Care Inc.
G01N27/3272A61B5/1411A61B5/1486A61B5/1495A61B5/14532A61B5/14546A61B5/14865A61B5/157A61B5/150022A61B5/15105A61B5/15113A61B5/15144A61B5/150358A61B5/150412C12Q1/001C12Q1/004C12Q1/006G01N27/3273G01N33/5438A61B2560/0223A61B2562/0295
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,234,864
App. No.
14/463,444
Granted
Jan 12, 2016
Kind
B2
Abstract

A sensor designed to determine the amount and concentration of analyte in a sample having a volume of less than about 1 μL. The sensor has a working electrode coated with a non-leachable redox mediator. The redox mediator acts as an electron transfer agent between the analyte and the electrode. In addition, a second electron transfer agent, such as an enzyme, can be added to facilitate the electrooxidation or electroreduction of the analyte. The redox mediator is typically a redox compound bound to a polymer. The preferred redox mediators are air-oxidizable. The amount of analyte can be determined by coulometry. One particular coulometric technique includes the measurement of the current between the working electrode and a counter or reference electrode at two or more times. The charge passed by this current to or from the analyte is correlated with the amount of analyte in the sample. Other electrochemical detection methods, such as amperometric, voltammetric, and potentiometric techniques, can also be used. The invention can be used to determine the concentration of a biomolecule, such as glucose or lactate, in a biological fluid, such as blood or serum. An enzyme capable of catalyzing the electrooxidation or electroreduction of the biomolecule is provided as a second electron transfer agent.

Claims (18)

1. A method for determining a concentration of an analyte in a body fluid of a patient, comprising the steps of:

transporting a body fluid sample of the patient into a sample chamber of a test strip, the sample chamber comprising a working electrode and a reference electrode and/or a counter electrode, wherein the sample chamber has a volume of 1 μl or less; and

determining the concentration of the analyte in the body fluid sample by measuring the charge passed through the working electrode over a period of time of within 1 minute after transporting the body fluid.

2. The method of claim 1 , wherein the sample chamber has a volume of 0.5 μl or less.

3. The method of claim 1 , wherein the sample chamber has a volume of 0.2 μl or less.

4. The method of claim 1 , wherein the sample chamber has a volume of 0.1 μl or less.

5. The method of claim 1 , wherein the sample chamber comprises a counter electrode and wherein the working electrode and the counter electrode are a facing electrode pair.

6. The method of claim 1 , wherein the test strip further includes an enzyme on the working electrode.

7. The method of claim 6 , wherein the enzyme is glucose oxidase or glucose dehydrogenase.

8. The method of claim 1 , wherein an enzyme is immobilized on the working electrode.

9. The method of claim 1 , wherein the test strip further includes a redox mediator on the working electrode.

10. The method of claim 9 , wherein the redox mediator is immobilized on the working electrode.

11. The method of claim 9 , wherein the redox mediator is an air-oxidizable redox mediator.

12. The method of claim 9 , wherein the redox mediator carries electrons directly to the working electrode.

13. The method of claim 9 , wherein the redox mediator comprises an osmium complex, a ferrocyanide, or a ferricyanide.

14. The method of claim 1 , wherein the analyte is glucose.

15. The method of claim 1 , wherein the working electrode is constructed of a material selected from gold, carbon, platinum, ruthenium dioxide and palladium.

16. The method of claim 1 , wherein the working electrode is separated from the counter or reference electrode by a distance of less than 200 micrometer.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2014
From: HELLER, ADAM; FELDMAN, BENJAMIN J.; SAY, JAMES; VREEKE, MARK S.
To: E. HELLER & COMPANY
Reel/Frame 034313/0407 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2014
From: E. HELLER & COMPANY
To: THERASENSE, INC.
Reel/Frame 034313/0433 →
CHANGE OF NAME Recorded Dec 2, 2014
From: THERASENSE, INC.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 034512/0782 →
Continuity (5)
Continuation 11035131 · Jan 13, 2005
Division 10457585 · Jun 9, 2003
Continuation 09413735 · Oct 6, 1999
Division 08795767 · Feb 6, 1997
Related Publication 20140353173A1 · Dec 4, 2014